"Trump's executive order signifies a pivotal moment in U.S. policy, as it actively promotes research into psychedelics like ibogaine, psilocybin, and MDMA for mental health treatment."
"The decision to support psychedelic research is driven by the staggering costs associated with treating PTSD in veterans, which amounts to $40 billion annually, alongside the urgent opioid crisis."
"The history of psychedelics began in 1943 with Dr. Albert Hofmann's synthesis of LSD, which later became a focal point in Cold War military psychological operations."
On April 18, Trump signed an executive order to expand research on psychedelics for mental health, particularly ibogaine. This marks a significant shift as the federal government actively promotes psychedelic research, previously only tolerated. Clinical trials for psilocybin and MDMA also receive support. The decision is influenced by the high costs of PTSD treatment for veterans and the opioid crisis. The history of psychedelics dates back to 1943 with the synthesis of LSD, which was used in military projects during the Cold War.
Read at english.elpais.com
Unable to calculate read time
Collection
[
|
...
]